Psoriatic Disease To Take Center Stage at the UN General Assembly: IFPA Calls for Greater Recognition of Psoriatic Disease During UN High-Level Meetings

Read more about this event and register: https://pages.devex.com/devex-at-unga-80 Read more about this event and register:https://pages.devex.com/devex-at-unga-80 Psoriatic disease is a lifelong, systemic inflammatory condition, often coexisting with other NCDs, such as diabetes, obesity, cardiovascular diseases and depression. An estimated 60 million people live with the disease. Despite the numbers, psoriatic disease has been overlooked in the health systems worldwide. The first...

STOCKHOLM, 11/09/2025 (informazione.news - comunicati stampa - salute e benessere)

Psoriatic disease is a lifelong, systemic inflammatory condition, often coexisting with other NCDs, such as diabetes, obesity, cardiovascular diseases and depression. An estimated 60 million people live with the disease. Despite the numbers, psoriatic disease has been overlooked in the health systems worldwide.

The first and only resolution on psoriasis was adopted by WHO in 2014, recognizing it as a major public health concern. Since then, the progress has been poor. IFPA is calling for a greater global commitment to ensure that the needs of people with psoriatic disease are integrated into global and national health policies.

To amplify this call, IFPA representatives are traveling to New York to participate in the upcoming United Nations High-Level Meeting on Noncommunicable Diseases (NCDs) - at UN Headquarters on September 25 . This event brings together health leaders, experts, and policymakers to shape the future of NCD prevention and care. IFPA is seizing this opportunity to advocate for more inclusive policies, improved access to care, and greater recognition of psoriatic disease within the broader NCD agenda.

As a part of this advocacy initiative, IFPA organizes a high-level conversation in partnership with   on the sidelines of UNGA, titled: . The event takes place at the Devex NCD Pavilion in New York on September, 22.

The session will feature Frida Dunger, Executive Director of IFPA, and Kate Reynolds, IFPA ambassador, living with psoriatic disease. The speakers will share powerful perspectives on why lived experience must move to the center of global health policymaking.

"  - shares .

" says  .

IFPA (the International Federation of Psoriasis Associations), founded in 1971 and based in Stockholm, Sweden , is the global organization dedicated to advocating for everyone affected by psoriatic disease. IFPA's members include national and regional patient associations and represent over 60 million people worldwide. Through global coalitions, World Psoriasis Day campaigns, the IFPA Forum, and the World Psoriasis & Psoriatic Arthritis Conference, IFPA is redefining psoriatic disease as a key lens for stronger, more inclusive health systems. Learn more:

Photo - https://mma.prnewswire.com/media/2771187/Frida_Dunger.jpg
Photo - https://mma.prnewswire.com/media/2771188/United_Nations_Headquarters_New_York.jpg 
Logo -  https://mma.prnewswire.com/media/2771186/IFPA_Logo.jpg

 

 

 

View original content:https://www.prnewswire.co.uk/news-releases/psoriatic-disease-to-take-center-stage-at-the-un-general-assembly-ifpa-calls-for-greater-recognition-of-psoriatic-disease-during-un-high-level-meetings-302554184.html